Technical Trading Overview for Novell Inc. (NOVL)

October 13, 2009

Inc. (NASDAQ: NOVL)

Inc. (NOVL) engages in the development and integration of mixed information technology environments worldwide. The Company operates in four segments: Open Platform Solutions, Identity and Security Management, Systems and Resource Management, and Workgroup. The Open Platform Solutions segment delivers Linux solutions for the enterprises. Its products include SUSE Linux Enterprise Server, an open source server operating system for professional deployment in heterogeneous IT environments; SUSE Linux Enterprise Desktop, a business desktop product that brings together the Linux operating environment with various business applications; openSUSE, a home computing product; and SUSE Engineering, a product development work for its customers. The Identity and Security Management segment integrates, secures, and manages IT assets. Its product line comprises Identity Manager, a data-sharing and synchronization solution; Access Manager that simplifies and safeguards online asset-sharing; SecureLogin, a directory-integrated authentication solution; Sentinel that automates the monitoring of IT effectiveness; eDirectory; and Compliance Management Platform. The Systems and Resource Management segment offers various products under ZENworks brand that protects the integrity of networks by centralizing, automating, and simplifying network management. The Workgroup segment provides workgroup solutions that offer infrastructure, services and tools, which customers require to collaborate across various devices. Read more

Popularity: unranked [?]

Technical Trading Overview for MDRNA Inc. (MRNA)

October 13, 2009

Inc. (NASDAQ: )

Inc. () is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). The Company’s infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications. Read more

Popularity: unranked [?]

Technical Trading Overview for Aurizon Mines Ltd. (AZK)

October 12, 2009

. (AMEX: )

. () a Canada-based gold producer with operations and development activities in the Abitibi region of Northwestern Quebec, one of the world’s most favorable mining jurisdictions and prolific gold and base metal regions. The Company owns 100% of the Casa Berardi gold mine; one advanced-stage project, the Joanna gold project; and one early stage exploration project, the Kipawa gold/uranium project. In addition, Aurizon Mines retains a gold-indexed royalty on future gold production from the Beaufor mine and Perron property. Read more

Popularity: unranked [?]

Technical Trading Overview For Converted Organics Inc. (COIN)

October 12, 2009

Converted Organics Inc (NASDAQ: )
Converted Organics Inc. () is engaged in the production of high-quality, all-natural, organic soil amendment and fertilizer products through food waste recycling. The Company uses its proprietary High Temperature Liquid Composting (HTLC) system, a proven, state-of-the-art microbial digestion technology, to process various biodegradable food wastes into dry pellet and liquid concentrate organic fertilizers that help grow healthier food and improve environmental quality. In addition to its sales in the agribusiness market, the Company sells and distributes its environmentally-friendly fertilizer products in retail and professional turf management markets. The Company operates two manufacturing facilities located in Woodbridge, New Jersey and Gonzales, California, while a third is under development in Johnston, Rhode Island. Read more

Popularity: unranked [?]

Trading Outlook for Sequenom Inc. (SQNM)

October 11, 2009

Sequenom Inc. (NASDAQ: )

Sequenom Inc. () focuses on providing of products, services, diagnostic testing, applications and genetic analysis products that translate genomic science into solutions for biomedical research, translational research, molecular medicine, and agricultural and livestock applications. Its development and commercialization efforts in various diagnostic areas include non-invasive prenatal diagnostics, oncology, infectious diseases and other disorders. The Company offers its MassARRAY® system for various DNA/RNA analysis applications, including single nucleotide polymorphism (SNP), genotyping detection of mutations, analysis of copy number variants, and other structural genome variations, as well as quantitative gene expression analysis, quantitative methylation marker analysis, comparative sequence analysis of haploid organisms, SNP discovery and oligonucleotide quality control. has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY® system and other platforms. Read more

Popularity: 1% [?]

Trading Outlook for CIT Group Inc. (CIT)

August 10, 2009

Group Inc. (NYSE: )

Group Inc. () operates as the holding company for bank, which provides commercial financing and leasing products, and management advisory services to the small and middle market companies worldwide. Its products principally include asset based loans; secured lines of credit; operating, capital and leveraged leases; vendor finance programs; import and export financing; debtor-in-possession/turnaround financing; acquisition and expansion financing; letters of credit/trade acceptances structuring; and small business loans.
Read more

Popularity: 4% [?]

Clicky Web Analytics